Camilla Krakstad

Bergen, 5021, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 154 publications

Integrated mutational landscape analysis of endometrial stromal sarcoma.

Integrated mutational landscape analysis of endometrial stromal sarcoma.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 27, 2026

High expression of the ADC target Claudin-6 associates with aggressive endometrial cancer and remains high in metastatic lesions.

High expression of the ADC target Claudin-6 associates with aggressive endometrial cancer and remains high in metastatic lesions.

Journal: BJC reports
Published: October 27, 2025

Toward reproducible metabolic tumor volume quantification in endometrial cancer: optimizing [¹⁸F]FDG PET/CT tumor segmentation methods.

Toward reproducible metabolic tumor volume quantification in endometrial cancer: optimizing [¹⁸F]FDG PET/CT tumor segmentation methods.

Journal: EJNMMI research
Published: September 23, 2025

It takes two to tango: importance of oestrogen receptor and progesterone receptor in endometrial cancer.

It takes two to tango: importance of oestrogen receptor and progesterone receptor in endometrial cancer.

Journal: The Lancet. Oncology
Published: September 05, 2025

ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment.

ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment.

Journal: European journal of cancer (Oxford, England : 1990)
Published: August 06, 2025

Molecular Landscape of Endometrial Stromal Tumors.

Molecular Landscape of Endometrial Stromal Tumors.

Journal: JCO precision oncology
Published: May 22, 2025

Co-expression of tissue factor, TROP2, and NECTIN4 in primary and matched metastatic cervical cancer lesions.

Co-expression of tissue factor, TROP2, and NECTIN4 in primary and matched metastatic cervical cancer lesions.

Journal: Translational oncology
Published: May 15, 2025

Pragmatic preoperative molecular classification of endometrial cancers; Replacing POLE sequencing with hormone receptor staining.

Pragmatic preoperative molecular classification of endometrial cancers; Replacing POLE sequencing with hormone receptor staining.

Journal: Gynecologic oncology
Published: February 25, 2025

Predicting aggressive disease and poor outcome in endometrial cancer using preoperative [18F]FDG PET primary tumor radiomics.

Predicting aggressive disease and poor outcome in endometrial cancer using preoperative [18F]FDG PET primary tumor radiomics.

Journal: European journal of nuclear medicine and molecular imaging
Published: February 11, 2025

Evaluation of early chemotherapy response by combining static- and dynamic [18F]FDG-PET with diffusion-weighted MRI in subcutaneous patient-derived endometrial cancer mouse models.

Evaluation of early chemotherapy response by combining static- and dynamic [18F]FDG-PET with diffusion-weighted MRI in subcutaneous patient-derived endometrial cancer mouse models.

Journal: EJNMMI research
Published: January 13, 2025

Improving pre-operative binary grading: relevance of p53 and PR expression in grade 2 endometrioid endometrial carcinoma.

Improving pre-operative binary grading: relevance of p53 and PR expression in grade 2 endometrioid endometrial carcinoma.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: January 06, 2025

Prognostic value of assessing ctDNA in patients with endometrial carcinoma - an international multicenter study.

Prognostic value of assessing ctDNA in patients with endometrial carcinoma - an international multicenter study.

Journal: Gynecologic oncology
Published: December 06, 2024
Showing 1-12 of 154

Last Updated: 09/26/2026